Trivium Point Advisory LLC Buys 586 Shares of Danaher Corporation $DHR

Trivium Point Advisory LLC boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 35.4% in the second quarter, HoldingsChannel reports. The firm owned 2,242 shares of the conglomerate’s stock after purchasing an additional 586 shares during the quarter. Trivium Point Advisory LLC’s holdings in Danaher were worth $443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently modified their holdings of DHR. NBC Securities Inc. bought a new stake in shares of Danaher in the first quarter valued at about $176,000. Affiance Financial LLC boosted its position in shares of Danaher by 54.6% in the first quarter. Affiance Financial LLC now owns 1,136 shares of the conglomerate’s stock valued at $233,000 after acquiring an additional 401 shares during the period. Merit Financial Group LLC boosted its position in shares of Danaher by 44.8% in the first quarter. Merit Financial Group LLC now owns 14,555 shares of the conglomerate’s stock valued at $2,984,000 after acquiring an additional 4,505 shares during the period. ST Germain D J Co. Inc. boosted its position in shares of Danaher by 18.0% in the first quarter. ST Germain D J Co. Inc. now owns 4,197 shares of the conglomerate’s stock valued at $860,000 after acquiring an additional 639 shares during the period. Finally, Capital Asset Advisory Services LLC boosted its position in shares of Danaher by 6.7% in the first quarter. Capital Asset Advisory Services LLC now owns 11,709 shares of the conglomerate’s stock valued at $2,402,000 after acquiring an additional 736 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 11.20% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently commented on DHR. UBS Group dropped their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Guggenheim reaffirmed a “buy” rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Barclays reaffirmed an “overweight” rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $245.91.

Danaher Stock Up 6.4%

Shares of NYSE DHR opened at $198.05 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The company has a market cap of $141.82 billion, a price-to-earnings ratio of 42.14, a PEG ratio of 2.65 and a beta of 0.75. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41. The stock has a 50-day moving average price of $199.55 and a two-hundred day moving average price of $197.31.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.